US 12133914
Hydrocortisone oral liquid formulations
granted A61KA61K31/573A61K47/10
Quick answer
US patent 12133914 (Hydrocortisone oral liquid formulations) held by Eton Pharmaceuticals, Inc. expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Eton Pharmaceuticals, Inc.
- Grant date
- Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/573, A61K47/10, A61K47/14, A61K47/183